Redefine what’s possible
With computational pathology revolutionizing the landscape of disease diagnosis and treatment, life sciences organizations must be ready to harness its full potential. Concentriq® LS is built to drive that evolution.
Serving as the central hub for AI-enabled scientific workflows from biomarker discovery to clinical trial execution, Concentriq LS unifies data, teams, and applications to unlock insights and accelerate R&D pipelines. By transforming siloed, underutilized data into a digital foundation enriched and optimized for AI, the platform empowers R&D teams to push the boundaries of pathology and bring life-saving diagnostics and therapies to patients faster.
Designed for the complexity and speed of modern science
Unified data, seamless collaboration
With data centralized in one platform, scientists across departments, teams, and partners collaborate in real-time to perform analyses and drive progress
Integration with tech ecosystem
Interoperability with leading scanners, LIMS, and image analysis apps. Eliminate vendor lock-in and stay at the forefront of innovation.
Enterprise scalability
Support for the highest-volume organizations managing complex pathology workflows across global sites and cross-functional teams.
Intuitive, adaptable workflows
Platform configurability based on your organization’s needs including automated processes that simplify logistics.
Built for AI
Digital data foundation and AI engine to build models that uncover new insights and enhance capabilities across the R&D pipeline.
Multimodal real-world data
Access to de-identified whole slide images matched to clinical and genomic data at scale. Incorporate data into studies and leverage for AI development.
40%
Reduction in time spent searching for data enterprise-wide
120+
AI apps for research available on Concentriq
60%
Accelerated workflow cycles, speeding time to market
13X
Faster AI development
10M+
Whole slide images in RWD database from 2M+ patients and growing
Powering insights and accelerating R&D at every stage
Concentriq LS empowers scientists and pathologists to collaborate across teams, work faster towards milestones, and unlock critical insights that drive faster decision-making.
DISCOVERY
Efficiently identify, explore, and mature high-quality candidates
- Unified, Organized Data: Unlock the power of the enterprise’s data by centralizing it in one AI-enabled platform
- Comprehensive Global Search: Readily access data to drive faster and more informed scientific decisions
- Best-in-Class AI Analysis: Build and run AI image analysis applications for biomarker quantification directly in R&D workflows for rapid insights
- All-in-One Viewer: Drive faster reviews for brightfield, fluorescence, and Z-stack imaging
- Research-Ready Real-World Data: Fuel novel biomarker discovery and target identification with exhaustive datasets
“Proscia’s Concentriq Platform is helping us drive value. We can combine all of our different image analyses under one roof, which I thought was a huge benefit. You can start to establish a common practice within images or pathology data.”
Principal Scientist
PRECLINICAL DEVELOPMENT
Get to clinical trial faster, with more confidence
- Purpose-Built Scoring Workflows: Boost productivity with optimized workflows for both primary and peer review
- AI-Powered Toxicity Assessments: Identify patterns that may correlate with drug safety and efficacy using leading AI analysis applications
- Built-In Compliance: Support GLP studies with audit logs and change-tracking for comprehensive traceability
- Real-Time Sharing and Collaboration: Speed up review cycles within and outside the organization
- Standardized Study Templates: Enhance efficiency and improve quality of research data
“Concentriq LS is the only platform that offers the robust feature set and scalability essential to meeting the evolving needs of our scientists and the biopharmaceutical organizations that we serve.”
Dr. Wendell P. Davis, Vice President of Pathology
CLINICAL DEVELOPMENT
Streamline trials and maximize success
- AI-Enabled Optimization: Improve reproducibility with standardized results and utilize AI-based biomarkers for targeted patient enrollment
- Compliance Readiness: Leverage advanced security and logging features designed to support GLP and GCP compliance
- Pathologist-Centric, Collaborative Experience: Speed up pathologist recruitment and onboarding with an intuitive, globally accessible platform, enabling faster project starts working with colleagues far and wide
- Automated Data Transfer in Bulk: Drive efficient data sharing at scale between sponsors and CROs
“Standardization [on Concentriq] aids in patient enrollment in clinical trials, stratification, randomization into treatment arms and endpoint evaluation.”
Dr. Amanda Hemmerich, Director of Digital Pathology Innovation
Unleash the power of AI to transform R&D
Concentriq LS is more than an AI-enabled platform. It empowers your organization to access, organize, and leverage proprietary and real-world data to build and deploy computational pathology AI applications that advance drug discovery and development.
Train and validate AI models with multimodal RWD
Access high-quality real-world data with a diverse array of cases to augment controlled clinical trial data and support the development of high-performing, clinically viable AI models.
Build novel AI models 13x faster
With Concentriq Embeddings — Proscia’s foundation model API—data scientists and AI engineers can seamlessly convert large datasets into numerical representations optimized for AI model building, leveraging state-of-the-art foundation models directly within Concentriq LS.
Run AI algorithms to accelerate R&D workflows
Incorporate advanced AI applications — including proprietary and third-party algorithms — directly into image analysis workflows. Transform R&D with AI-powered capabilities from automated image QC to enhanced toxicity assessments, patient stratification, and endpoint measurements.
Life sciences leaders run Concentriq LS
Life sciences leaders run Concentriq LS
Concentriq LS is trusted by leading life sciences organizations, including 14 of the top 20 pharmaceutical companies, to advance their precision medicine portfolios with pathology and AI.
CASE STUDY
Leading Biopharma Company Boosts Innovation and Efficiency
Learn how one of top global pharmaceutical companies using Concentriq LS has streamlined workflows and enhanced collaboration to increase pathologists’ efficiency, accelerate the process of getting new medicines to patients, and gain more value across the drug development pipeline.
Learn More About Concentriq LS
Learn More About Concentriq LS
Webinar
Genentech, PathGroup and Proscia Discuss How Digital Pathology Is Fueling Precision Medicine with Unprecedented Real-World Data
Webinar
IQVIA Laboratories: Streamlining Clinical Development and Maximizing Trial Success with an Enterprise Pathology Platform
Webinar
Bioptimus and Proscia: Unlocking the Promise of Foundation Models in Pathology for AI-Driven Drug Discovery and Development
Poster
Bayer: Real-Time Messaging of Pathological Diagnoses from Toxicology LIMS to Cloud-Based Digital Pathology Web Application
Discover how Concentriq LS can accelerate your therapeutic development programs
Connect with us today to schedule a personalized demo from a life sciences digital pathology expert.